文献速递糖尿病

法国1型或2型糖尿病患者启动瞬感扫描式葡萄糖监测后急性糖尿病并发症住院率显著下降:RELIEF研究

Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study.
PubMed 文献 · Diabetes Care · 2021-04-20

RELIEF研究基于法国国家理赔数据库,纳入74,011例启动FreeStyle Libre的1型或2型糖尿病患者,比较启动前后12个月急性糖尿病并发症住院率。结果显示,1型糖尿病急性并发症住院下降49.0%,2型糖尿病下降39.4%;酮症酸中毒、糖尿病相关昏迷等均显著减少,12个月持续使用率达98.1%。

要点

  • 启动瞬感扫描式葡萄糖监测后,1型糖尿病急性并发症住院率下降49.0%,2型糖尿病下降39.4%。
  • 酮症酸中毒住院在1型糖尿病下降56.2%,2型糖尿病下降52.1%;糖尿病相关昏迷分别下降39.6%和31.9%。
  • 2型糖尿病低血糖和高血糖住院分别下降10.8%和26.5%;12个月持续使用率98.1%。

核心结论

  • 使用瞬感扫描式葡萄糖监测与酮症酸中毒及糖尿病相关昏迷住院发生率显著降低相关。

研究设计与样本

  • 回顾性研究,从法国国家理赔数据库识别74,011例启动FreeStyle Libre的1型或2型糖尿病患者。
  • 根据启动前自我血糖监测试纸获取情况对患者进行亚分类。
  • 记录启动前后各12个月内酮症酸中毒、严重低血糖、糖尿病相关昏迷和高血糖的住院情况。

主要发现

  • 急性糖尿病并发症住院在1型糖尿病下降49.0%,在2型糖尿病下降39.4%。
  • 酮症酸中毒住院在1型糖尿病下降56.2%,在2型糖尿病下降52.1%。
  • 糖尿病相关昏迷住院在1型糖尿病下降39.6%,在2型糖尿病下降31.9%。
  • 2型糖尿病低血糖住院下降10.8%,高血糖住院下降26.5%。
  • 启动前不依从自我血糖监测者及试纸获取量最高者住院最明显,启动后分别下降54.0%和51.2%;12个月持续使用率98.1%。

临床怎么用

  • 对于1型或2型糖尿病患者,启动瞬感扫描式葡萄糖监测可能有助于降低急性并发症住院风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The RELIEF study assessed rates of hospitalization for acute diabetes complications in France before and after initiation of the FreeStyle Libre system. RESEARCH DESIGN AND METHODS: A total of 74,011 patients with type 1 diabetes or type 2 diabetes who initiated the FreeStyle Libre system were identified from the French national claims database with use of ICD-10 codes, from hospitalizations with diabetes as a contributing diagnosis, or the prescription of insulin. Patients were subclassified based on self-monitoring of blood glucose (SMBG) strip acquisition prior to starting FreeStyle Libre. Hospitalizations for diabetic ketoacidosis (DKA), severe hypoglycemia, diabetes-related coma, and hyperglycemia were recorded for the 12 months before and after initiation. RESULTS: Hospitalizations for acute diabetes complications fell in type 1 diabetes (-49.0%) and in type 2 diabetes (-39.4%) following FreeStyle Libre initiation. DKA fell in type 1 diabetes (-56.2%) and in type 2 diabetes (-52.1%), as did diabetes-related comas in type 1 diabetes (-39.6%) and in type 2 diabetes (-31.9%). Hospitalizations for hypoglycemia and hyperglycemia decreased in type 2 diabetes (-10.8% and -26.5%, respectively). Before initiation, hospitalizations were most marked for people noncompliant with SMBG and for those with highest acquisition of SMBG, which fell by 54.0% and 51.2%, respectively, following FreeStyle Libre initiation. Persistence with FreeStyle Libre at 12 months was at 98.1%. CONCLUSIONS: This large retrospective study on hospitalizations for acute diabetes complications shows that a significantly lower incidence of admissions for DKA and for diabetes-related coma is associated with use of flash glucose monitoring. This study has significant implications for patient-centered diabetes care and potentially for long-term health economic outcomes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Roussel R, Riveline JP, Vicaut E, et al. Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study. Diabetes Care. 2021. PMID: 33879536. doi:10.2337/dc20-1690

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。